Eversept Partners, LP NBIX Holdings History
Eversept Partners, LP's Neurocrine Biosciences Inc Holding Summary
As of 2025-03-31, Eversept Partners, LP held 167,243.00 shares of Neurocrine Biosciences Inc(NBIX), totaling $18.50 Mil. This investment constitutes 1.88% of their stock portfolio, and Eversept Partners, LP now holds 0.17% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2025Q1. And since then Eversept Partners, LP has made 1 purchases of NBIX, at an average price of $126.68, for a total of 167,243.00 shares. Based on historical transaction data and NBIX's current price of $131.64, Eversept Partners, LP's estimated gain on his NBIX holdings is $829,525.28, reflecting a 3.92% gain to date.
Eversept Partners, LP NBIX ($131.64) Holding Chart
Eversept Partners, LP NBIX ($131.64) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
